Table 6. Biochemical examination (mean ± s).
| Group | ALT (U) | AST (U) | Bun (mmol/L) | Cr (μmol/L) |
|---|---|---|---|---|
| normal control group | 27.8 ± 6.0 | 104.1 ± 10.2 | 4.8 ± 1.2 | 57.0 ± 4.3 |
| saline control group | 28.5 ± 3.9 | 103.2 ± 8.6 | 5.6 ± 0.7 | 55.8 ± 6.1 |
| adriamycin group | 33.2 ± 1.6 | 108.3 ± 5.3 | 5.5 ± 1.2 | 52.4 ± 5.7 |
| nuclide-alone group | 28.1 ± 3.9 | 105.4 ± 10.3 | 5.2 ± 1.2 | 53.6 ± 6.6 |
| MFH-alone group | 28.2 ± 4.8 | 109.8 ± 8.8 | 5.3 ± 1.1 | 55.5 ± 7.6 |
| nuclide-gene group | 27.8 ± 3.7 | 106.6 ± 9.3 | 5.2 ± 1.2 | 54.4 ± 7.3 |
| nuclide-gene-MFH group | 25.1 ± 4.0 | 107.2 ± 6.5 | 5.3 ± 0.8 | 54.6 ± 3.9 |
ALT, AST, BUN and Cr have no differences between all the therapeutic groups and normal control group or saline control group (p > 0.05).